Bio Protocol vs Compound — how do they compare? Bio Protocol trades at Rp517.88 (market cap Rp1,15T, Rp264,79M 24h volume), while Compound trades at Rp305,192 (market cap Rp3,05T, Rp147,9M 24h volume). The key difference: Compound is far larger — about 2.7× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Compound's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Compound for 94 Days on average.
| BIO | COMP | |
|---|---|---|
Market Cap | Rp1,15T | Rp3,05T |
Volume (24h) | Rp264,79M | Rp147,9M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 10M COMP |
Typical Hold Time | 16 Days | 94 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Compound (COMP) is trading at Rp305,192 with a market cap of Rp3.05 trillion, showing a bearish technical signal as moving averages indicate selling pressure while oscillators remain neutral. The token is currently near its pivot point of Rp305,106, with key support at Rp298,303 and resistance at Rp309,963. Recent on-chain activity shows a hold time of 94 days, suggesting reduced short-term trading interest. No major protocol upgrades or ecosystem developments have been reported recently, keeping fundamental drivers subdued amid broader market conditions.
Overall outlook is cautious with downside risks due to bearish technical structure and lack of positive catalysts. Key opportunities include potential rebounds from support levels if broader crypto sentiment improves. Major risks involve low liquidity, regulatory uncertainty for DeFi tokens, and high volatility. Investors should monitor network activity and exchange volume for signs of renewed interest.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Compound is a decentralized finance (DeFi) protocol that allows users to earn interest on their cryptocurrencies. It aims to create a liquid money market for cryptocurrencies by setting interest rates on loans using an algorithm based on market dynamics in real-time.
Read more on COMP →